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categories. Other risk factors include high levels of cooked fish and meat consumption, and some occupational exposures Epidemiologic studies have suggested that aromatic amines (2). However, the primary etiology of human pancreatic cancer (and nitroaromatic hydrocarbons) may be carcinogenic for is still poorly understood.
human pancreas. Pancreatic tissues from 29 organ donors
A common link among these risk factors may be a means (13 smokers, 16 non-smokers) were examined for their of exposure to aromatic amines and nitroaromatic hydrocarability to metabolize aromatic amines and other carcinobons, and it has been hypothesized that these agents may be gens. Microsomes showed no activity for cytochrome P450 carcinogenic to human pancreas (3,4). About 30 aromatic (P450) 1A2-dependent N-oxidation of 4-aminobiphenyl amines, including 2-naphthylamine and 4-aminobiphenyl have (ABP) or for the following activities (and associated P450s) : been detected in nanogram quantities in mainstream cigarette aminopyrine N-demethylation and ethylmorphine Nsmoke and in even higher levels in sidestream smoke (5).
demethylation (P450 3A4); ethoxyresorufin O-deethylation
Aromatic amines are also found in coal-and shale-derived (P450 1A1) and pentoxyresorufin O-dealkylation (P450 oils (6) and in agricultural chemicals (7) and they are used in 2B6); p-nitrophenol hydroxylation and N-nitrosodimethyla variety of industrial processes (8). amine N-demethylation (P450 2E1); lauric acid ω-
The carcinogenicity of aromatic amines, such as ABP (4-hydroxylation (P450 4A1); and 4-(methylnitrosamino)-1-aminobiphenyl),2-naphthylamine and benzidine, has long (3-pyridyl-1-butanol) (NNAL) and 4-(methylnitrosamino)-been established in both humans and experimental animals 1-(3-pyridyl)-1-butanone (NNK) α-oxidation (P450 1A2, (9). More recently, a variety of highly mutagenic hetero-2A6, 2D6). Antibodies were used to examine microsomal cyclic amines have been found in cooked foods (10); the levels of P450 1A2, 2A6, 2C8/9/18/19, 2E1, 2D6, and 3A3/ most abundant include 2-amino-3-methylimidazo[4,5-f]-4/5/7 and epoxide hydrolase. Immunoblots detected only quinoline (IQ*) 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaepoxide hydrolase at low levels; P450 levels were Ͻ1% of line (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyriliver. Microsomal benzidine/prostaglandin hydroperoxidadine (PhIP) and 2-amino-α-carboline (AαC). PhIP and IQ tion activity was low. In pancreatic cytosols and microare also present in mainstream cigarette smoke (11). These somes, 4-nitrobiphenyl reductase activities were present at chemicals are potent mutagens and are known to be carcinogens levels comparable to human liver. The O-acetyltransferase in rodents, inducing tumors in several organs (12). IQ is also activity (AcCoA-dependent DNA-binding of [ 3 H]Na powerful hepatocarcinogen in a non-human primate (13). hydroxy-ABP) of pancreatic cytosols was high, about twoNitroaromatic hydrocarbons are widespread environmental thirds the levels measured in human colon. Cytosols showed contaminants (14) and have been detected in food (15). Some high activity for N-acetylation of p-aminobenzoic acid, but of these agents are both very potent bacterial mutagens and not of sulfamethazine, indicating that acetyltransferase-1 animal carcinogens (14). Although the importance of nitro-(NAT1) is predominantly expressed in this tissue. Cytosolic aromatic hydrocarbons in the induction of human cancer is sulfotransferase was detected at low levels. Using 32 Ppresently unknown, truck drivers exposed to diesel emission, a particularly rich source of these compounds, are reported to are believed to be activated to potential DNA alkylating species cancer induction (33) . In the present study, we examined were conducted as previously described (29) . Prostaglandin H synthase activity pancreatic tissues from organ donors for their metabolic was measured as previously described (44 (39) . The assays were performed at 37°C in argon-saturated, 50 mM sodium pyrophosphate buffer (pH 7.0) containing 1 mM dithiothreitol, 2 mg/ ml calf thymus DNA, 0.25-1.0 mg/ml cytosolic protein, 1 mM AcCoA, and Table I . Summary of oxidative metabolism by human pancreatic 100 µM radiolabeled N-hydroxy-ABP. The DNA binding reactions were microsomes terminated after 15 min by the addition of 2 volumes of water-saturated n-butanol. The DNA was isolated by multiple solvent extractions and precipitaSubstrate activity Major Rates tions and the extent of AcCoA-dependent covalent binding of N-OH-ABP to enzyme DNA was estimated by liquid scintillation counting. The DNA binding associated Smokers (n) Non-smokers reactions were pseudo first-order and were linear with time for up to 15 min. with (n) Sulfotransferase activity was measured in a manner similar to the 3Ј-activity phosphoadenosine-5Ј-phosphosulfate-dependent covalent binding of N-OH-ABP to DNA as previously described (52).
ABP N-oxidation a P450 1A2 Ͻ1 (7) Ͻ1 (10) PABA N-acetyltransferase activity (NAT1) was measured in two ways, first
Aminopyrine N-demethylation a P450 3A4 Ͻ500 (7) Ͻ500 (10) by the disappearance of substrate as determined by the Bratton-Marshall
Ethylmorphine N-demethylation a P450 3A4 Ͻ500 Ͻ500 colorimetric procedure (53). Second, PABA N-acetyltransferase, in addition
Ethoxyresorufin O-deethylation a P450 1A1 Ͻ50 Ͻ50 to SMZ (sulfamethazine) N-acetyltransferase activities were determined using
Pentoxyresorufin O-dealkylation a P450 2B6 Ͻ50 Ͻ50 HPLC. Reactions were carried out using 1 mM dithriothreitol, 500 µM p-Nitrophenol hydroxylation a P450 2E1 Ͻ200 Ͻ500 AcCoA, and 100 µM PABA or 500 µM SMZ, at 37°C under conditions, N-nitrosodimethylamine P450 2E1 Ͻ500 Ͻ500 which were linear with respect to time (15 min) and protein concentration demethylation a (0.5-1 mg/ml), and were terminated by the addition of cold trichloroacetic Lauric acid ω-hydroxylation a P450 4A1 Ͻ5 Ͻ5 acid (final concentration 4%). AcCoA was omitted from the blanks. Acetylated NNK, NNAL α-oxidation a P450 1A2 Ͻ0.02 (6) Ͻ0.02 (4) PABA and SMZ were quantified by HPLC as previously described (54, 55) .
Benzidine peroxidation b PHS c 1.6 Ϯ 1.5 (8) 1.5 Ϯ 1.0 (10) There was no association observed between enzyme activity level and length of post-cross-clamp time.
a Rates are expressed in pmol/min/mg protein.
Gel electrophoresis and immunoblotting
b Results are expressed as pmol substrate bound/mg DNA/50 µg protein/5 Immunochemical staining for P450 protein levels was performed as previously min Ϯ SD. described (56). Microsomal protein (100 µg) from human pancreas were c PHS, prostaglandin H-synthase. separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis according to the method of Laemmli (57) using a 4-15% gradient slab gel. Protein bands were then electrophoretically transferred onto nitrocellulose to be catalysed by the specific P450s that are prevalent in membranes by the Western immunoblotting technique as described by Towbin human liver and in extrahepatic tissues (Table I) thereby, plays a major role in their metabolic activation.
N-Acetyltransferase genotyping
However, N-oxidation activity for ABP was not detected in DNA was isolated from nuclear pellets obtained during differential centrifugamicrosomal preparations from any of the samples examined tion as described above by the method of Gupta (66) . Polymorphisms in the (n ϭ 17; 10 non-smokers, seven smokers, including two human N-acetyltransferase gene, NAT2, were determined as described by Blum et al. (67) . Briefly, DNA extracted from tissue samples was amplified alcoholics). The rate in both smokers and non-smokers was by PCR (polymerase chain reaction) using specific oligonucleotides primers Ͻ1 pmol/min/mg protein; by comparison, the rate of ABP Nand then analyzed for the presence of three mutant alleles known to be oxidation in human liver microsomes (n ϭ 21) was 574 predominant in the US population (68) . The DNA was subjected to 25 cycles Ϯ 416 pmol/min/mg protein (47) . We also examined these (Table I) on PEI-cellulose plates and developed as previously described (72) . Adducts were visualized as dark spots on X-ray film after subjecting the thin-layer rate of NNK α-hydroxylation and carbonyl reduction in human plates to autoradiography. The corresponding region on the thin-layer plate liver microsomes was 0.5 and 5.1 pmol/min/mg protein, was then excised and radioactivity determined by scintillation counting.
respectively.
Putative ABP-adducts were identified by chromatographic comparison with
Microsomal prostaglandin H-synthase activity (n ϭ 18; 8 the ABP-adduct standard and quantitated by comparing the radioactivity in the sample spot with the corresponding spot observed for the adduct standard.
smokers, 10 non-smokers) was measured using either [ 3 H]ABP or [ 3 H]benzidine as substrate (Table I) . The results showed Results only a very low level of activity with benzidine (1-3 pmol Oxidative metabolism by human pancreas microsomes bound/mg DNA), which corresponds to~3-10% of the activity observed in human urinary bladder (39) . Pancreatic tissue microsomes were examined for their ability to carry out a variety of metabolic reactions that are known
The presence of P450s, as well as epoxide hydrolase, was (77), we sought to determine whether or not both enzymes were present in this tissue. Using PABA as substrate, under also investigated through immunological methods. Antibodies to epoxide hydrolase and to cytochromes P450 1A1/1A2, assay conditions that have shown it to be a selective substrate for NAT1 (78), we detected activity for NAT1 (Table III) in 2A6, 2C8/9/18/19, 2E1, 2D6, and 3A3/4/5/7 were used in immunoblots of pancreatic microsomes (n ϭ 10, six smokers, all the cytosols assayed (n ϭ 21, seven smokers, 14 nonsmokers). Using SMZ as substrate, under assay conditions that four non-smokers). Of these, only epoxide hydrolase was detected at low levels;~1% of liver (data not shown); in all have been shown to be selective for NAT2 (79), we detected very low activity in 9/21 samples; however, the activity samples tested, the levels of P450s were Ͻ1% of liver.
detected was Ͻ5% of that reported for human colon (80);
4-Nitrobiphenyl reductase activity of pancreas microsomes
and, upon NAT2 genotyping of these samples, there was no and cytosols association between SMZ activity and the presence of the Exposure to the carcinogenic metabolites of nitroaromatic rapid acetylator allele (NAT2*4) (data not shown). hydrocarbons may occur through nitroreduction of these agents Sulfotransferase activity for N-hydroxy-ABP (Table III) , to their corresponding N-hydroxy aromatic amine derivatives which is catalysed in humans selectively by the thermostable (23). Thus, it was of interest to examine the tissue preparations phenol sulfotransferases (53), was also measured in pancreatic for nitroreductase activity (Table II) . Microsomal 4-nitrobicytosols (n ϭ 8, two smokers, six non-smokers) and was found phenyl reductase activity was found in all the pancreatic tissues only at low levels (2-4% of liver activity). examined (n ϭ 27, 12 smokers, 15 non-smokers) and at high DNA adducts levels, similar to that found in human lung and liver (74).
HPLC analyses showed the formation of both N-hydroxy-ABP
Post-labeling analysis of pancreatic DNA (n ϭ 29, 13 smokers, 16 non-smokers) for putative aromatic amine-DNA adducts, (5-20%) and ABP (80-95%) as reduction products, the relative yields of which varied with different samples. We then explored revealed a number of radiolabelled spots, but there was no apparent association with current smoking status. In eight of the possibility that the NADPH-cytochrome P450 reductase might be the enzyme responsible for the 4-nitrobiphenyl 29 tissue DNA samples, we observed the presence of an adduct (Figure 1 ) that was chromatographically identical to the major reductase activity, since Hall et al. (75) had detected this protein in human pancreatic ductal cells (but not exocrine ABP-DNA adduct, N-(deoxyguanosin-8-yl)-ABP. This adduct was detected in DNA from both smokers (5/13) and noncells), using an immunostaining technique. Accordingly, we examined P450 reductase activity via a photometric assay; smokers (3/16) and was not observed using the nuclease P1 enhancement method, which is known to cause selective 3Ј-however, the detected activity levels of P450 reductase showed no significant correlation with the levels of 4-nitrobiphenyl dephosphorylation of guanine-C8-substituted aromatic amine-DNA adducts and subsequent inactivity for 32 P-post-labeling. reductase activity.
Cytosolic preparations were also assayed for 4-nitrobiphenyl The overall adduct levels were relatively low, in the range of 0.2 to 1.1 adducts per 10 8 nucleotides. reductase (n ϭ 8, two smokers, six non-smokers) and appreciable activity was detected, at levels that were similar to those found in the microsomes. 4-Nitrobiphenyl reduction did not Discussion occur when hypoxanthine or N 1 -methyl-nicotinamide were Pancreatic cancer is associated with several risk factors that substituted for the NADPH/NADH-generating system, sugmake plausible the involvement of carcinogenic aromatic gesting that neither xanthine oxidase nor aldehyde oxidase amines and nitroaromatic hydrocarbons in the etiology of participate in the reduction of this nitro compound. this disease (2,4). These chemical agents, however, require Metabolic esterification by human pancreas cytosols activation to DNA-reactive species in order to exert their carcinogenic effect (21) . This study was undertaken to investi-O-Acetyltransferase activity of pancreatic cytosols (Table III) , as measured by AcCoA-dependent DNA-binding of [ 3 H]Ngate the capacity of human pancreas to metabolically activate arylamines and other carcinogens, and to examine whether or OH-ABP, was at high levels, comparable to approximately two-thirds the levels seen in human colon (76) . All 29 samples not aromatic amine-DNA adducts are present in this tissue. Nitrosamines have also been suggested as human carcinoshowed significant activity. Since both the NAT1 and NAT2 can carry out the O-acetylation of N-hydroxy aromatic amines gens. These compounds are present in the human diet (17) and at high levels in cigarette smoke (17). The Surgeon General's report of 1989 (34) suggested NNK as the putative human pancreatic carcinogen in cigarette smoke. Moreover, nitrosamines induce pancreatic cancers in several animal models (81, 82) . Thus, the metabolism of tobacco-specific nitrosamines were of interest in this tissue analysis. There is evidence from human tissues that metabolism of NNK is carried out by several P450s, including 1A2, 2A6, 2B6, 2E1, 2F1, 3A5 and to a small extent, by other enzymes as well (83) . Our data indicate that, unlike rodents, enzymes which activate these carcinogens are not present in the human pancreas. This does not rule out a role for these compounds in pancreatic carcinogenesis, for example, via activation in the liver. However, the presence of enzymes involved in arylamine metabolism in the pancreas favors an alternative hypothesis in the human. Several enzyme systems are known to be involved in the metabolic activation of carcinogenic aromatic amines (21) . P450 1A2, which catalyzes the initial N-oxidation of these agents, could not be detected, either by enzyme assay or by immunochemical analysis, in any of the pancreatic tissue samples (including those from smokers) examined in this study. Tissue samples from smokers and non-smokers were in the human pancreas is consistent with data that have failed to detect P450 1A2 from many human extrahepatic tissues (86). Attempts to detect other P450s involved in carcinogen or drug metabolism in the same tissue samples also were unsuccessful.
Our negative findings are inconsistent with those of Foster et al. (87) who reported the immunohistochemical detection of P450s in pancreatic tissue from organ donors. Levels of these enzymes were higher in pancreas samples from patients with chronic pancreatitis and pancreatic cancer. The reasons for this difference between our findings and theirs are uncertain, but may reflect a lower limit of detection with cytochemical methods. We also examined the tissue samples for the presence of prostaglandin H-synthase because an alternative pathway for aromatic amine metabolism involves peroxidative activation in the target tissue, as has been demonstrated in human urinary bladder and prostate tissues (39, 88) . However, this pathway appears to be of negligible importance in human pancreas.
The metabolic activation of nitroaromatic hydrocarbons involves conversion to the N-hydroxy derivative through reduction of the nitro group (23) . In contrast to the absence of Noxidation, nitroreductase activity was found in all tissue samples. Rates for the reduction of 4-nitrobiphenyl were comparable with those of microsomal and cytosolic preparations from human lung and liver tissues (74). These results demonstrate the capacity of pancreas to catalyse the reductive metabolism of carcinogenic nitroaromatic hydrocarbons to their N-hydroxy derivatives, thus providing a critical pathway for their metabolic activation. Although there is no strong epidemiologic evidence associating nitroaromatic hydrocarbons with pancreatic cancer, such capacity may underlie elevated risks associated with certain exposures, such as combustion products (89), jet fuel exhaust (90) and coke oven emissions (91). The identity of the nitroreductase activities remain unclear. Several enzymes can catalyse the reduction of nitroaromatics, including microsomal NADPH-cytochrome and aldehyde oxidase (80) . Activity for the former was found to be present in all of the tissue samples examined; however, in smokers and also in those individuals with certain dietary and environmental exposures. there was no correlation between this activity and the total nitroreductase activity, which suggests that multiple enzymes are likely to be involved in the pancreas. suggests a pathway for metabolic activation of arylamines and nitroaromatics in the pancreas similar to that proposed for References human urinary bladder (92,93) and human peripheral lung (74).
Although aromatic amine N-oxidation did not occur in the NAT1 activity was found in all tissue samples examined. These findings may help to explain the etiology of this disease
